Jozef Bossowski PhD
About Jozef Bossowski PhD
Jozef Bossowski, PhD, is a Postdoctoral Researcher at NYU Langone Health with extensive experience in preclinical translational oncology, specializing in immuno-therapies for resistant cancers.
Current Position at NYU Langone Health
Since 2019, Jozef Bossowski, PhD, has been working as a Postdoctoral Researcher at NYU Langone Health. His work focuses on preclinical translational oncology with an emphasis on KRAS and P53 biology. His research investigates immuno-therapies for resistant cancers, contributing to innovative treatment strategies through his extensive expertise.
Past Experience at C3M - Centre Méditerranéen de Médecine Moléculaire
Jozef Bossowski worked as a Doctoral Researcher at C3M - Centre Méditerranéen de Médecine Moléculaire from 2014 to 2018. During his four-year tenure, he developed significant proficiency in CRISPR/Cas9 gene-editing techniques, particularly in the identification of essential genes both in vivo and in vitro.
Education and Degrees Achieved
Jozef Bossowski has a comprehensive academic background. He earned two Master’s degrees from Jagiellonian University: one in Immunology (2010-2015) and another in Biotechnology (2010-2014). Additionally, he achieved a degree in Cell and Molecular Biology from Université Côte d'Azur between 2015 and 2017. These qualifications support his extensive research capabilities in the field of oncology.
Global Laboratory Experience
Jozef Bossowski has accumulated diverse laboratory experiences in the United States, France, and Poland. This global perspective has enriched his research approach through collaborations across different cultures. His time at institutions like the Institut de Génétique Moléculaire de Montpellier (2013) and Róża Wiatrów (2014) has contributed to his holistic understanding of molecular genetics and beyond.
Specialization in Immuno-Oncology
Jozef Bossowski specializes in immuno-oncology, focusing on the exploration of metabolic adaptations, cell cycle regulation, and inflammation. His multidisciplinary approach includes analyzing immune responses and investigating cellular processes, contributing to the broader field of cancer research.